Last reviewed · How we verify

NCT06084455: TMS-EEGxercise

TMS-evoked Potentials During Aerobic Exercise

Completed NA Last updated 7 February 2025
What this trial tests

NA trial testing Aerobic exercise in Transcranial Magnetic Stimulation in 30 participants. Completed in 4 February 2025.

Timeline
15 October 2023
Primary endpoint
4 February 2025
4 February 2025

Quick facts

Lead sponsorAalborg University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment30
Start date15 October 2023
Primary completion4 February 2025
Estimated completion4 February 2025
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Aalborg University

Who can join

Adults 18 to 60, any sex, with Transcranial Magnetic Stimulation or Electroencephalography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigates the modification of the local-to-global connectivity pattern in response to a session of aerobic exercise. Transcranial magnetic stimulation (TMS) will be applied to elicit electroencephalography (EEG) responses in healthy volunteers. The TMS-evoked potentials (TEPs) will be recorded and serve as a reflection of cortical reactivity and connectivity to TMS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Aerobic exercise

Trials testing the same drug.

Other recruiting trials for Transcranial Magnetic Stimulation

Currently open trials in the same condition.

Other Aalborg University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06084455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing